DNLI logo

Denali Therapeutics (DNLI) Long Term Liabilities

Annual Total Long Term Liabilities

$44.98 M
-$8.91 M-16.53%

December 31, 2023


Summary


Performance

DNLI Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDNLIbalance sheetmetrics:

Quarterly Long Term Liabilities

$48.42 M
+$7.44 M+18.16%

September 30, 2024


Summary


Performance

DNLI Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDNLIbalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

DNLI Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-16.5%+18.2%
3 y3 years-88.2%-10.1%
5 y5 years-45.4%-10.1%

DNLI Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-29.3%at low-23.9%+18.2%
5 y5-year-88.2%at low-87.5%+18.2%
alltimeall time-88.2%+565.3%-87.5%+616.2%

Denali Therapeutics Long Term Liabilities History

DateAnnualQuarterly
Sep 2024
-
$48.42 M(+18.2%)
Jun 2024
-
$40.98 M(-4.8%)
Mar 2024
-
$43.03 M(-4.3%)
Dec 2023
$44.98 M(-16.5%)
$44.98 M(-4.8%)
Sep 2023
-
$47.27 M(-4.6%)
Jun 2023
-
$49.55 M(-3.9%)
Mar 2023
-
$51.56 M(-4.3%)
Dec 2022
$53.89 M(-15.3%)
$53.89 M(-3.1%)
Sep 2022
-
$55.63 M(-7.1%)
Jun 2022
-
$59.85 M(-3.0%)
Mar 2022
-
$61.69 M(-3.0%)
Dec 2021
$63.63 M(-83.3%)
$63.63 M(-83.4%)
Sep 2021
-
$383.44 M(-0.6%)
Jun 2021
-
$385.70 M(-0.6%)
Mar 2021
-
$387.89 M(+1.5%)
DateAnnualQuarterly
Dec 2020
$382.05 M(+238.1%)
$382.05 M(+364.0%)
Sep 2020
-
$82.34 M(-5.0%)
Jun 2020
-
$86.71 M(-15.8%)
Mar 2020
-
$102.92 M(-8.9%)
Dec 2019
$113.00 M(+37.2%)
$113.00 M(-4.3%)
Sep 2019
-
$118.10 M(+1.9%)
Jun 2019
-
$115.88 M(-0.7%)
Mar 2019
-
$116.70 M(+41.7%)
Dec 2018
$82.35 M(+1118.1%)
$82.35 M(+59.4%)
Sep 2018
-
$51.68 M(+1.8%)
Jun 2018
-
$50.77 M(-12.1%)
Mar 2018
-
$57.76 M(+754.3%)
Dec 2017
$6.76 M(-98.1%)
$6.76 M(-3.7%)
Sep 2017
-
$7.02 M(-98.0%)
Dec 2016
$356.12 M(+629.2%)
$356.12 M
Dec 2015
$48.84 M
-

FAQ

  • What is Denali Therapeutics annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Denali Therapeutics?
  • What is Denali Therapeutics annual total long term liabilities year-on-year change?
  • What is Denali Therapeutics quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Denali Therapeutics?
  • What is Denali Therapeutics quarterly long term liabilities year-on-year change?

What is Denali Therapeutics annual total long term liabilities?

The current annual total long term liabilities of DNLI is $44.98 M

What is the all time high annual total long term liabilities for Denali Therapeutics?

Denali Therapeutics all-time high annual total long term liabilities is $382.05 M

What is Denali Therapeutics annual total long term liabilities year-on-year change?

Over the past year, DNLI annual total long term liabilities has changed by -$8.91 M (-16.53%)

What is Denali Therapeutics quarterly total long term liabilities?

The current quarterly long term liabilities of DNLI is $48.42 M

What is the all time high quarterly long term liabilities for Denali Therapeutics?

Denali Therapeutics all-time high quarterly total long term liabilities is $387.89 M

What is Denali Therapeutics quarterly long term liabilities year-on-year change?

Over the past year, DNLI quarterly total long term liabilities has changed by +$7.44 M (+18.16%)